Older article from 2019:

https://www.npr.org/sections/health-shots/2019/05/12/7222165...

>Internal divisions and pressure from Congress also limited the FDA's response to overseas violations,

whistles

>delays in launching a generic version of Lipitor could cost Americans up to $18 million a day, according to a 2011 letter from a group of U.S. senators to the FDA commissioner.